Cited by 107Cardiac Fibrosis and RemodelingConnective Tissue Growth Factor ResearchSignaling Pathways in Disease

Wnt-induced secreted protein-1 is a prohypertrophic and profibrotic growth factor

Colston, J. T., de la Rosa, S. D., Koehler, M., Gonzales, K., Mestril, R., Freeman, G. L., Bailey, S. R., Chandrasekar, B.·2007·American Journal of Physiology-Heart and Circulatory Physiology

Abstract

Wnt1-induced secreted protein-1 (WISP-1) is a member of the cysteine-rich 61, connective tissue growth factor, and nephroblastoma overexpressed (CCN) family of growth factors and is expressed in the heart at low basal levels. The purpose of this study was to investigate whether WISP-1 is upregulated in postinfarct myocardium and whether WISP-1 exerts prohypertrophic and mitogenic effects stimulating myocyte hypertrophy, cardiac fibroblast (CF) proliferation, and collagen expression. Male C57Bl/6 (25 g) mice underwent permanent occlusion of the left anterior descending coronary artery. mRNA and protein levels were analyzed by Northern and Western blot analyses. Cardiomyocyte hypertrophy was quantified by protein and DNA synthesis. CF proliferation was quantified by CyQuant assay, and soluble collagen release by Sircol assay. A time-dependent increase in WISP-1 expression was detected in vivo in the noninfarct zone of the left ventricle, which peaked at 24 h (3.1-fold, P < 0.01). Similarly, biglycan expression was increased by 3.71-fold (P < 0.01). IL-1beta and TNF-alpha expression preceded WISP-1 expression in vivo and stimulated WISP-1 expression in neonatal rat ventricular myocytes in vitro. WISP-1-induced cardiomyocyte hypertrophy was evidenced by increased protein (2.78-fold), but not DNA synthesis, and enhanced Akt phosphorylation and activity. Treatment of primary CF with WISP-1 significantly stimulated proliferation at 48 h (6,966 +/- 264 vs. 5,476 +/- 307 cells/well, P…

Integrity signals

Registry

Crossref · 10.1152/ajpheart.00428.2007

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • WISP1 promotes cytoprotection in multiple cell types through pathways that require PI 3-K and Akt and, in microglia, involve mTOR and PRAS40.

    “WISP1 promotes cytoprotection in multiple cell types through pathways that not only require phosphatidylinositol-3-kinase (PI 3-K) and protein kinase B (Akt) [7, 8, 10, 11, 20, 21], but also utilize pathways in microglia that involve the mammalian target of rapamycin (mTOR) and the proline rich Akt substrate 40 kDa (PRAS40) [13].”

Cited by

Sorted by citations

Authors
Colston, J. T., de la Rosa, S. D., Koehler, M., Gonzales, K., Mestril, R., Freeman, G. L., Bailey, S. R., & Chandrasekar, B.
Affiliations
  • The University of Texas at San Antonio Health Science Center (US)
  • Loyola University Chicago (US)
Venue
American Journal of Physiology-Heart and Circulatory Physiology
Published
2007-09
Volume
293
Issue
3
Pages
H1839-H1846
ISSN
  • 0363-6135 (ISSN-L)
  • 1522-1539
OpenAlex
W2107187767
Cited by
107
References
0
Citations by year
2026: 2 · 2025: 2 · 2024: 4 · 2023: 2 · 2022: 2 · 2021: 7 · 2020: 5 · 2019: 7 · 2018: 5 · 2017: 10 · 2016: 3 · 2015: 16 · 2014: 3 · 2013: 7 · 2012: 13
FWCI
3.52
Type
journal article
Language
en
Open access
closed
Locations
  • American Journal of Physiology-Heart and Circulatory Physiology (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Heart, Lung, and Blood Institute (HL67971, R01HL068020, HL68020, R01HL067971)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Connective Tissue Growth Factor Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
Keywords
WISP1, biglycan, myocardial infarction, cardiomyocyte hypertrophy, cardiac fibroblast proliferation, myocardial fibrosis, extracellular matrix, Akt signaling, IL-1β, TNF-α, post-infarction remodeling
MeSH terms
Animals, Cells, Cultured, Disease Models, Animal, Fibroblasts, Fibrosis, Hypertrophy, Male, Mice, Inbred C57BL, Myocardial Infarction, Myocardium, Proteoglycans, Proto-Oncogene Proteins, Tumor Necrosis Factor-alpha, Oncogene Proteins, Up-Regulation, Extracellular Matrix Proteins, Rats, Sprague-Dawley, Myocytes, Cardiac, Intercellular Signaling Peptides and Proteins, Cell Proliferation, Mice, Rats, CCN Intercellular Signaling Proteins, Biglycan

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review